Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Who is Not a Good Candidate for MRSA Prodrug TXA709?

SEP 03, 2017 | CONTAGION® EDITORIAL STAFF


Daniel Pilch, PhD, associate professor, Rutgers Robert Wood Johnson Medical School, explains which patients would not make good candidates for MRSA prodrug TXA709. Dr. Pilch shares that TXA709 is capable of treating life-threatening bloodstream infections as well as skin and soft tissue infections. MRSA is also known for infecting bone; although distribution studies suggest that the drug can treat bone infections, more research still needs to be done.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
Big advances in treatment can